As the 2023 AGM season starts, our voting and shareholder engagement are reinforcing each other, says Rogier Snijdewind.
Senior Advisor Responsible Investment
PGGM aims to enhance both access and affordability of medicines through various ways, such as investing in companies that are contributing to having a positive impact on SDG 3 (Good Health and Wellbeing) and by running a dedicated Access to Healthcare engagement program with investee companies.
Investors finance the different links that together form the global production chains for medical devices, pharmaceutical and other care-related products. Governments and companies must ensure that these products are available all over the world.
Manufacturers of pharmaceuticals take inappropriate risks if they charge excessive prices for their medications. As a shareholder, we do not want to see maximisation of profit at the expense of health care.